Folke Hammarqvist
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Folke Hammarqvist has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Jan Wernerman
Department of Anesthesiology and Intensive Care Medicine, Karolinska University Hospital Huddinge, Sweden
3 shared publications Jan Wernerman
2 shared publicationsAlexandra VON DER Decken
1 shared publicationBjörn Carlsson
Research Center for Endocrinology and Metabolism, Department of Internal Medicine, Sahlgrenska Hospital (M.H., R.B.W., R.B., B.C., L.M.S.C.), Goteborg
1 shared publicationCecilia Strömberg
1 shared publicationErik Vinnars
1 shared publication
Latest Publications
- 28 February 2009
- Published by Elsevier in e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism
- Vol. 4 (1) , e4-e6
Basics in clinical nutrition: Injury and sepsis – The neuroendocrine response
- 28 February 2009
- Published by Elsevier in e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism
- Vol. 4 (1) , e4-e6
Basics in clinical nutrition: Injury and sepsis – The neuroendocrine response
- 31 December 2006
- Published by Elsevier in Clinical Nutrition
- Vol. 25 (6) , 869-870
In memory of Erik Vinnars
- 31 December 2006
- Published by Elsevier in Clinical Nutrition
- Vol. 25 (6) , 869-870
In memory of Erik Vinnars
- 30 April 2005
- Published by Elsevier in Clinical Nutrition
- Vol. 24 (2) , 236-243
Free amino acid and glutathione concentrations in muscle during short-term starvation and refeeding
- 30 April 2005
- Published by Elsevier in Clinical Nutrition
- Vol. 24 (2) , 236-243
Free amino acid and glutathione concentrations in muscle during short-term starvation and refeeding
- 1 March 2004
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 7 (2) , 183-187
Can it all be done by enteral nutrition?
During recent years techniques and metabolic considerations have been discussed intensively. One contributing reason is that results have not always been easy to interpret and introduce into clinical practice. Nutrition through the enteral and parenteral route has classically been compared, and this is the topic of this review. During the past 2 years a growing number of studies have focused on the amount and type of nutrition that is possible to give by enteral nutrition to intensive care unit patients. How to handle the clinical problem with paralysis and gastroparesis has also been studied. Basic research has shown a link between the gastrointestinal tract, immunocompetence and nutritional status. More evidence now exists that this is also clinically valid. Recent research has shown that enteral nutrition alone does not cover the total nutritional needs of intensive care unit patients. Enteral nutrition given early in a high dose is associated with a higher risk of complications. Metabolism in intensive care unit patients is different from the perioperative condition, which has been highlighted in recent studies with important clinical implications. The final solution has not been found yet, if it exists at all, and research in this field will continue. As the situation in biology and in real intensive care unit life is neither black nor white, it would be most beneficial for the intensive care unit patient if enteral nutrition and parenteral nutrition joined together in a good balance in order to avoid underload and overload.
- 1 March 2004
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 7 (2) , 183-187
Can it all be done by enteral nutrition?
During recent years techniques and metabolic considerations have been discussed intensively. One contributing reason is that results have not always been easy to interpret and introduce into clinical practice. Nutrition through the enteral and parenteral route has classically been compared, and this is the topic of this review. During the past 2 years a growing number of studies have focused on the amount and type of nutrition that is possible to give by enteral nutrition to intensive care unit patients. How to handle the clinical problem with paralysis and gastroparesis has also been studied. Basic research has shown a link between the gastrointestinal tract, immunocompetence and nutritional status. More evidence now exists that this is also clinically valid. Recent research has shown that enteral nutrition alone does not cover the total nutritional needs of intensive care unit patients. Enteral nutrition given early in a high dose is associated with a higher risk of complications. Metabolism in intensive care unit patients is different from the perioperative condition, which has been highlighted in recent studies with important clinical implications. The final solution has not been found yet, if it exists at all, and research in this field will continue. As the situation in biology and in real intensive care unit life is neither black nor white, it would be most beneficial for the intensive care unit patient if enteral nutrition and parenteral nutrition joined together in a good balance in order to avoid underload and overload.
- 1 February 1997
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 82 (2) , 421-428
Measurement of Human Growth Hormone Receptor Messenger Ribonucleic Acid by a Quantitative Polymerase Chain Reaction-Based Assay: Demonstration of Reduced Expression after Elective Surgery*
Studies of GH receptor (GHR) gene expression in human tissues have been hampered by the limited amount of tissue available for analysis and the low sensitivity of conventional methods. We have developed a quantitative reverse transcriptase-PCR assay for measurement of GHR messenger ribonucleic acid levels in small human tissue biopsies. To compensate for sample to sample variation, an internal RNA standard, which differs from the wild-type GHR transcript by only a few nucleotides, was reverse transcribed and amplified together with the GHR transcripts. PCR was carried out using one biotinylated primer to permit the purification of single stranded PCR products on streptavidin-coated microtiter plates. The ratio between the wild-type and mutated transcripts was determined by two separate minisequence reactions in which a primer, annealed immediately 3′ of a variable nucleotide, was extended by a single 3H-labeled nucleotide, complementary to either the wild-type or mutated sequence. The assay range was 0.125–8 × 105 transcripts/sample, the mean intraassay coefficient of variation was 8.7%, and the lower limit of detection was 0.125 × 105 transcripts/sample. GHR messenger ribonucleic acid levels were detectable in small amounts (10–100 ng) of total RNA extracted from adipose tissue, skeletal muscle, and liver. The GHR gene expression in liver was approximately 10-fold higher than that in skeletal muscle, whereas intermediate levels were found in adipose tissue. In nine patients undergoing elective abdominal surgery, GHR gene expression in skeletal muscle was reduced on day 3 after surgery compared to the baseline level. The decrease in GHR gene expression was accompanied by a decrease in skeletal muscle glutamine. This suggests that the postoperative protein catabolism may be caused at least partly by acquired GH insensitivity due to reduced expression of the GHR gene.
- 1 February 1997
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 82 (2) , 421-428
Measurement of Human Growth Hormone Receptor Messenger Ribonucleic Acid by a Quantitative Polymerase Chain Reaction-Based Assay: Demonstration of Reduced Expression after Elective Surgery*
Studies of GH receptor (GHR) gene expression in human tissues have been hampered by the limited amount of tissue available for analysis and the low sensitivity of conventional methods. We have developed a quantitative reverse transcriptase-PCR assay for measurement of GHR messenger ribonucleic acid levels in small human tissue biopsies. To compensate for sample to sample variation, an internal RNA standard, which differs from the wild-type GHR transcript by only a few nucleotides, was reverse transcribed and amplified together with the GHR transcripts. PCR was carried out using one biotinylated primer to permit the purification of single stranded PCR products on streptavidin-coated microtiter plates. The ratio between the wild-type and mutated transcripts was determined by two separate minisequence reactions in which a primer, annealed immediately 3′ of a variable nucleotide, was extended by a single 3H-labeled nucleotide, complementary to either the wild-type or mutated sequence. The assay range was 0.125–8 × 105 transcripts/sample, the mean intraassay coefficient of variation was 8.7%, and the lower limit of detection was 0.125 × 105 transcripts/sample. GHR messenger ribonucleic acid levels were detectable in small amounts (10–100 ng) of total RNA extracted from adipose tissue, skeletal muscle, and liver. The GHR gene expression in liver was approximately 10-fold higher than that in skeletal muscle, whereas intermediate levels were found in adipose tissue. In nine patients undergoing elective abdominal surgery, GHR gene expression in skeletal muscle was reduced on day 3 after surgery compared to the baseline level. The decrease in GHR gene expression was accompanied by a decrease in skeletal muscle glutamine. This suggests that the postoperative protein catabolism may be caused at least partly by acquired GH insensitivity due to reduced expression of the GHR gene.
- 1 August 1992
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 216 (2) , 184-191
Biosynthetic Human Growth Hormone Preserves Both Muscle Protein Synthesis and the Decrease in Muscle-free Glutamine, and Improves Whole-body Nitrogen Economy After Operation
As a reproducible human trauma model, patients (n = 17) undergoing elective cholecystectomy were studied for 3 postoperative days. They were randomly allocated to receive either recombinant human growth hormone (hGH; 0.3 U/kg/24 hours) or placebo together with total parenteral nutrition, including 0.2 gN/kg/24 hours and 135 kJ/kg/24 hours. Before operation and on the third postoperative day, percutaneous muscle biopsies were performed to determine the concentration and size distribution of ribosomes and the free amino acid concentrations. The significant postoperative decrease in the total ribosome concentration (15.3 +/- 6.4%) and the polyribosome concentration (20.9 +/- 6.5%) in the control group was impeded in the group receiving synthetic hGH. Muscle free glutamine decreased by 35.6 +/- 4.2% in the control group and to a lesser extent in the group that was given hGH after operation (p less than 0.05). The protein content of skeletal muscle was unchanged. The cumulated nitrogen balance for the study period was negative in the control group (-7.09 +/- 0.71 gN), but was not different from zero in the hGH group (-2.32 +/- 1.66 gN). It is concluded that synthetic hGH administered after operation has beneficial effects on the whole-body nitrogen economy, as indicated by the unchanged capacity for protein synthesis in skeletal muscle, the preserved levels of muscle free glutamine, and improvement in the whole-body nitrogen balance. The effects of hGH on skeletal muscle protein and amino acid metabolism can explain the postoperative nitrogen-sparing effect attributed to hGH.
- 1 August 1992
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 216 (2) , 184-191
Biosynthetic Human Growth Hormone Preserves Both Muscle Protein Synthesis and the Decrease in Muscle-free Glutamine, and Improves Whole-body Nitrogen Economy After Operation
As a reproducible human trauma model, patients (n = 17) undergoing elective cholecystectomy were studied for 3 postoperative days. They were randomly allocated to receive either recombinant human growth hormone (hGH; 0.3 U/kg/24 hours) or placebo together with total parenteral nutrition, including 0.2 gN/kg/24 hours and 135 kJ/kg/24 hours. Before operation and on the third postoperative day, percutaneous muscle biopsies were performed to determine the concentration and size distribution of ribosomes and the free amino acid concentrations. The significant postoperative decrease in the total ribosome concentration (15.3 +/- 6.4%) and the polyribosome concentration (20.9 +/- 6.5%) in the control group was impeded in the group receiving synthetic hGH. Muscle free glutamine decreased by 35.6 +/- 4.2% in the control group and to a lesser extent in the group that was given hGH after operation (p less than 0.05). The protein content of skeletal muscle was unchanged. The cumulated nitrogen balance for the study period was negative in the control group (-7.09 +/- 0.71 gN), but was not different from zero in the hGH group (-2.32 +/- 1.66 gN). It is concluded that synthetic hGH administered after operation has beneficial effects on the whole-body nitrogen economy, as indicated by the unchanged capacity for protein synthesis in skeletal muscle, the preserved levels of muscle free glutamine, and improvement in the whole-body nitrogen balance. The effects of hGH on skeletal muscle protein and amino acid metabolism can explain the postoperative nitrogen-sparing effect attributed to hGH.